id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-09 06:19:29
expired found date
-
created at
2024-06-21 13:54:05
updated at
2026-01-19 08:23:52
length
12
crc
54130
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
600162
mp size raw text
9030
mp inner links count
3
mp inner links status
20 (imported)
title
Home - Allogene
description
LEADING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR T™ PLATFORM INNOVATION Multiplex gene-engineering and gene-editing capabilities Proprietary lymphodepletion platform State-of-the-art manufacturing
site name
Allogene
author
updated
2025-12-30 18:31:29
raw text
Home - Allogene Skip to content CONTACT US CAREERS Share ABOUT US AT A GLANCE MANAGEMENT TEAM BOARD OF DIRECTORS SCIENTIFIC ADVISORS PARTNERS AlloCAR T™ HISTORY OF CAR T NEXT REVOLUTION IN CELL THERAPY PLATFORM FOR TOMORROW ON-DEMAND AVAILABILITY PIPELINE AlloCAR T™ PIPELINE DATABRIEF CLINICAL TRIALS EXPANDED ACCESS SCIENTIFIC PUBLICATIONS OUR CULTURE ESG REPORT WE ARE ONE ALLOGENE REVOLUTIONIZING CELL THERAPY DIVERSITY, EQUITY, INCLUSION AND BELONGING JOIN THE ALLOGENE COMMUNITY NEWS CENTER PRESS RELEASES EVENTS PERSPECTIVES OUR TWEETS COMMUNITY GUIDELINES INVESTORS IR OVERVIEW NEWS & EVENTS PRESS RELEASES EVENTS PRESENTATIONS STOCK INFORMATION STOCK QUOTE & CHART HISTORIC PRICE LOOKUP INVESTMENT CALCULATOR CORPORATE GOVERNANCE DOCUMENTS & CHARTERS ESG REPORT BOARD OF DIRECTORS MANAGEMENT COMMITTEE COMPOSITION FINANCIALS & FILINGS SEC FILINGS RESOURCES INVESTOR FAQs EMAIL ALERTS...
redirect type
30 (window.location)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
6709
text words
1125
text unique words
355
text lines
352
text sentences
10
text paragraphs
6
text words per sentence
112
text matched phrases
19
text matched dictionaries
5
links self subdomains
0
links other subdomains
69 - ir.allogene.com
links other domains
1
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
1
links ext ugc
11 - linkedin.com, twitter.com, facebook.com, tumblr.com, reddit.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-30 18:31:29
rss path
rss status
32 (unknown)
rss found date
2024-03-09 16:36:09
rss size orig
15482
rss items
10
rss spam phrases
0
rss detected language
1 (English)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
20
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-09 06:19:29
sitemap process date
2024-11-30 12:09:55
sitemap first import date
-
sitemap last import date
2026-01-19 08:23:52